Alpha 2.0
Login Register
» Authors » Sebastian Marciano

Sebastian Marciano

Explore the profile of Sebastian Marciano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 103
Citations 811
Followers 0
Related Specialties
Gastroenterology
General Medicine
Microbiology
Top 10 Co-Authors
Adrian Gadano
Margarita Anders
Melisa Dirchwolf
Manuel Mendizabal
Marcelo Silva
Federico Pinero
Ezequiel Ridruejo
Carla Bermudez
Leila Haddad
Lucas McCormack
Published In
Ann Hepatol
Liver Int
Eur J Gastroenterol Hepatol
Acta Gastroenterol Latinoam
JHEP Rep
Affiliations
Soon will be listed here.
Recent Articles
11.
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting
Nadim M, Kellum J, Forni L, Francoz C, Asrani S, Ostermann M, et al.
J Hepatol . 2024 Mar; 81(1):163-183. PMID: 38527522
Patients with cirrhosis are prone to developing acute kidney injury (AKI), a complication associated with a markedly increased in-hospital morbidity and mortality, along with a risk of progression to chronic...
12.
Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list
Gomez Perdiguero G, Spina J, Martinez J, Savluk L, Saidman J, Bonifacio M, et al.
JHEP Rep . 2024 Feb; 6(3):100985. PMID: 38384670
Background & Aims: Malnutrition, sarcopenia, and frailty are prevalent in cirrhosis. We aimed to assess the correlation between assessment tools for malnutrition, sarcopenia, and frailty in patients on the liver...
13.
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections-Results from the ICA "Global Study" (EABCIR-Global Study)
Maiwall R, Piano S, Singh V, Caraceni P, Alessandria C, Fernandez J, et al.
Hepatology . 2023 Dec; 79(5):1019-1032. PMID: 38047909
Background: The administration of an appropriate empirical antibiotic treatment is essential in cirrhosis and severe bacterial infections. We aimed to investigate the predictors of clinical response of empirical antibiotic treatment...
14.
Sociodemographic and clinical characteristics and access to health care in patients with spinal muscular atrophy in Argentina
Vazquez G, Nasif S, Marciano S, Pagotto V
Front Neurol . 2023 Sep; 14:1179692. PMID: 37745665
The FAME registry gathers the majority of patients with SMA in Argentina. From it, the clinical, sociodemographic and access to treatment characteristics were analyzed in 322 patients (range 8 months-61 ...
15.
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study
Chau A, Yeh M, Tsai P, Huang D, Kim S, Trinh H, et al.
Clin Gastroenterol Hepatol . 2023 Sep; 22(3):572-580.e5. PMID: 37734582
Background & Aims: It is unclear if there may be sex differences in response to nucleos(t)ide analogs including virologic response (VR), biochemical response (BR), complete response (CR), and hepatocellular carcinoma...
16.
Association Between Selective Serotonin Reuptake Inhibitors Prevalent Use and COVID-19-Related Mortality: A Retrospective Cohort Study
Osores P, Vivacqua M, Vazquez C, Marciano S, Giunta D, Faccioli J
J Clin Psychopharmacol . 2023 Sep; 43(5):411-416. PMID: 37683229
Purpose/background: Since the emergence of the coronavirus disease 2019 (COVID-19), many efforts have been made to prevent and to treat the disease. In this line, the anti-inflammatory effect of selective...
17.
Integrated analysis of the transcriptome and its interaction with the metabolome in metabolic associated fatty liver disease: Gut microbiome signatures, correlation networks, and effect of PNPLA3 genotype
Mascardi M, Mazzini F, Suarez B, Ruda V, Marciano S, Casciato P, et al.
Proteomics . 2023 Jul; 23(18):e2200414. PMID: 37525333
Interactions between communities of the gut microbiome and with the host could affect the onset and progression of metabolic associated fatty liver disease (MAFLD), and can be useful as new...
18.
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
Diaz L, Fuentes-Lopez E, Ayares G, Idalsoaga F, Arnold J, Ayala Valverde M, et al.
JHEP Rep . 2023 Jul; 5(8):100727. PMID: 37456675
Background & Aims: Model for End-Stage Liver Disease (MELD) score better predicts mortality in alcohol-associated hepatitis (AH) but could underestimate severity in women and malnourished patients. Using a global cohort,...
19.
Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study
Intagliata N, Rahimi R, Higuera-de-la-Tijera F, Simonetto D, Farias A, Mazo D, et al.
Gastroenterology . 2023 Jun; 165(3):717-732. PMID: 37271290
Background & Aims: Hospitalized patients with cirrhosis frequently undergo multiple procedures. The risk of procedural-related bleeding remains unclear, and management is not standardized. We conducted an international, prospective, multicenter study...
20.
Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
Farias A, Curto Vilalta A, Momoyo Zitelli P, Pereira G, Goncalves L, Torre A, et al.
Gastroenterology . 2023 Jun; 165(3):696-716. PMID: 37263305
Background & Aims: Genetic ancestry or racial differences in health outcomes exist in diseases associated with systemic inflammation (eg, COVID-19). This study aimed to investigate the association of genetic ancestry...